161 related articles for article (PubMed ID: 29069662)
1. AF1q Contributes to Adriamycin-Induced Podocyte Injury by Activating Wnt/β-Catenin Signaling.
Zhang H; Ren R; Du J; Sun T; Wang P; Kang P
Kidney Blood Press Res; 2017; 42(5):794-803. PubMed ID: 29069662
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1.
Chen Q; Chen J; Wang C; Chen X; Liu J; Zhou L; Liu Y
FASEB J; 2020 Nov; 34(11):14424-14439. PubMed ID: 32888352
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of Wt1 activates Wnt/β-catenin signaling through modulating endocytic route of LRP6 in podocyte dysfunction in vitro.
Jing Z; Wei-jie Y; Yi-Feng ZG
Cell Signal; 2015 Sep; 27(9):1772-80. PubMed ID: 26049137
[TBL] [Abstract][Full Text] [Related]
4. Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.
He W; Kang YS; Dai C; Liu Y
J Am Soc Nephrol; 2011 Jan; 22(1):90-103. PubMed ID: 21030600
[TBL] [Abstract][Full Text] [Related]
5. Zona occludens-2 protects against podocyte dysfunction induced by ADR in mice.
Bautista-García P; Reyes JL; Martín D; Namorado MC; Chavez-Munguía B; Soria-Castro E; Huber O; González-Mariscal L
Am J Physiol Renal Physiol; 2013 Jan; 304(1):F77-87. PubMed ID: 23034938
[TBL] [Abstract][Full Text] [Related]
6. Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis.
Zhou D; Wang Y; Gui Y; Fu H; Zhou S; Wang Y; Bastacky SI; Stolz DB; Liu Y
Kidney Int; 2022 Jul; 102(1):96-107. PubMed ID: 35341792
[TBL] [Abstract][Full Text] [Related]
7. Fractalkine is Involved in Lipopolysaccharide-Induced Podocyte Injury through the Wnt/β-Catenin Pathway in an Acute Kidney Injury Mouse Model.
Senouthai S; Wang J; Fu D; You Y
Inflammation; 2019 Aug; 42(4):1287-1300. PubMed ID: 30919150
[TBL] [Abstract][Full Text] [Related]
8. [Low dose of triptolide ameliorates podocyte epithelial-mesenchymal transition induced by high dose of D-glucose via inhibiting Wnt3α/β-catenin signaling pathway activation].
Shi G; Wu W; Wan YG; Hex HW; Tu Y; Han WB; Liu BH; Liu YL; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(1):139-146. PubMed ID: 29552824
[TBL] [Abstract][Full Text] [Related]
9. Wnt/β-catenin links oxidative stress to podocyte injury and proteinuria.
Zhou L; Chen X; Lu M; Wu Q; Yuan Q; Hu C; Miao J; Zhang Y; Li H; Hou FF; Nie J; Liu Y
Kidney Int; 2019 Apr; 95(4):830-845. PubMed ID: 30770219
[TBL] [Abstract][Full Text] [Related]
10. CXCR4 induces podocyte injury and proteinuria by activating β-catenin signaling.
Mo H; Ren Q; Song D; Xu B; Zhou D; Hong X; Hou FF; Zhou L; Liu Y
Theranostics; 2022; 12(2):767-781. PubMed ID: 34976212
[No Abstract] [Full Text] [Related]
11. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.
Dai C; Stolz DB; Kiss LP; Monga SP; Holzman LB; Liu Y
J Am Soc Nephrol; 2009 Sep; 20(9):1997-2008. PubMed ID: 19628668
[TBL] [Abstract][Full Text] [Related]
12. beta-Catenin mediates adriamycin-induced albuminuria and podocyte injury in adult mouse kidneys.
Heikkilä E; Juhila J; Lassila M; Messing M; Perälä N; Lehtonen E; Lehtonen S; Sjef Verbeek J; Holthofer H
Nephrol Dial Transplant; 2010 Aug; 25(8):2437-46. PubMed ID: 20237062
[TBL] [Abstract][Full Text] [Related]
13. Mutual antagonism of Wilms' tumor 1 and β-catenin dictates podocyte health and disease.
Zhou L; Li Y; He W; Zhou D; Tan RJ; Nie J; Hou FF; Liu Y
J Am Soc Nephrol; 2015 Mar; 26(3):677-91. PubMed ID: 25071087
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.
Zhou L; Liu Y
Nat Rev Nephrol; 2015 Sep; 11(9):535-45. PubMed ID: 26055352
[TBL] [Abstract][Full Text] [Related]
15. Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy.
Chen L; Chen DQ; Wang M; Liu D; Chen H; Dou F; Vaziri ND; Zhao YY
Chem Biol Interact; 2017 Aug; 273():56-72. PubMed ID: 28578904
[TBL] [Abstract][Full Text] [Related]
16. Effect of Tang-Shen-Ning decoction on podocyte epithelial-esenchymal transformation via inhibiting Wnt/β-catenin pathway in diabetic mice.
Cui FQ; Gao YB; Wang YF; Meng Y; Cai Z; Shen C; Jiang XC; Zhao WJ
Ann Palliat Med; 2021 Dec; 10(12):12921-12936. PubMed ID: 32921066
[TBL] [Abstract][Full Text] [Related]
17. Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria.
Wang D; Dai C; Li Y; Liu Y
Kidney Int; 2011 Dec; 80(11):1159-1169. PubMed ID: 21832980
[TBL] [Abstract][Full Text] [Related]
18. β-Arrestin 1/2 Aggravates Podocyte Apoptosis of Diabetic Nephropathy via Wnt/β-Catenin Pathway.
Wang Y; Li H; Song SP
Med Sci Monit; 2018 Mar; 24():1724-1732. PubMed ID: 29572435
[TBL] [Abstract][Full Text] [Related]
19. Recombinant expression and purification of AF1q and its interaction with T-cell Factor 7.
Khan N; Park J; Dean WL; Gray RD; Tse W; Lee D; Sabo TM
Protein Expr Purif; 2020 Jan; 165():105499. PubMed ID: 31541685
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-Catenin Signaling Mediated-UCH-L1 Expression in Podocytes of Diabetic Nephropathy.
Zhang H; Luo W; Sun Y; Qiao Y; Zhang L; Zhao Z; Lv S
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
